Summary
- Current Price
- As of today, INSM price is $123.74, down -2.05% on
- Current Price All-Time High
- INSM price is currently -41.84% below its historical high of $212.75 set on
- Market Cap
- INSM current market cap is $27B, up +0.20% over the past 365 days
- Revenue
- INSM current annual revenue is $606.42M, up +66.73% year-over-year
- Next Earnings
- The next earnings release for INSM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Insmed Incorporated |
| Ticker | NASDAQ: INSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | insmed.com |
| Employees | 1,271 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $123.74 | |
| Price, 1D Change | -2.05% | |
| Market Cap | $27B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.46 | |
| Revenue | $606.42M | |
| Revenue, 1Y Change | +66.73% | |
| EPS | -$6.42 | |
| EPS, 1Y Change | -15.17% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | INSMD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$6.42 | |
| EPS Estimate | -$1.49 | N/A |
| EPS Est. Change | +76.84% | N/A |
| Revenue | $606.42M | |
| Revenue Estimate | $1.81B | N/A |
| Revenue Est. Change | +197.88% | N/A |
| Current Price | $123.74 | |
| Price Target | $197.50 | - |
| Price Tgt. Change | +59.61% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.34 | -$5.57 | -4.32% | |
| -$5.87 | -$6.42 | -9.24% | |
| -$1.49 | N/A | +76.84% | |
| $0.82 | N/A | +112.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $360.57M | $363.71M | +0.87% | |
| $605.46M | $606.42M | +0.16% | |
| $1.81B | N/A | +197.88% | |
| $2.87B | N/A | +372.83% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -3.14% | |
| Price, 3Y | +454.89% | |
| Market Cap, 1Y | +0.20% | |
| Market Cap, 3Y | +748.87% | |
| Revenue, 1Y | +66.73% | |
| Revenue, 3Y | +147.16% | |
| EPS, 1Y | -15.17% | |
| EPS, 3Y | -63.92% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $123.74 | |
| SMA 200 | $145.50 | |
| SMA 50 | $107.72 | |
| EMA 200 | $126.93 | |
| EMA 50 | $113.77 | |
| MACD | $5.81 | |
| Beta | 0.46 | |
| ATR | $6.09 | |
| 14-Day RSI | 59.74 | |
| 10-Day Volatility | 176.03% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $606.42M | |
| EPS | -$6.42 | |
| Gross Profit | $477.48M | |
| Gross Margin | 78.74% | |
| Operating Income | -$994.78M | |
| Operating Margin | -164.04% | |
| Net Income | -$1.28B | |
| Net Margin | -210.54% | |
| EBITDA | -$978.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 1.02 | |
| 3.83 | ||
| 3.54 | ||
| - | ||
| 4 | ||
| 6.66 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 23.75 | ||
| 35.67 | ||
| -33.62 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $738.98M | |
| $1.43B | ||
| $2.26B | ||
| $1.79B | ||
| $1.53B | ||
| $468.87M | ||
| Total Debt | $755.99M | |
| $19.26M | ||
| $79.91M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.88B | ||
| $1.47B | ||
| $128.94M | ||
| $0.00 | ||
| $16.45M | ||
| $0.00 | ||
| $5.03M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$935.01M | ||
| -$64.58M | ||
| $954.07M | ||
| Capex | $62.56M | |
| -$997.58M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Truist Securities | → | |
| JP Morgan | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Evercore ISI Group | → | |
| BMO Capital | ||
| Wells Fargo | → | |
| Guggenheim | → | |
| Evercore ISI Group | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
No data
Screeners with INSM
FAQ
- What is the ticker symbol for Insmed Incorporated?
- The ticker symbol for Insmed Incorporated is NASDAQ:INSM
- Does Insmed Incorporated pay dividends?
- No, Insmed Incorporated does not pay dividends
- What sector is Insmed Incorporated in?
- Insmed Incorporated is in the Healthcare sector
- What industry is Insmed Incorporated in?
- Insmed Incorporated is in the Biotechnology industry
- What country is Insmed Incorporated based in?
- Insmed Incorporated is headquartered in United States
- When did Insmed Incorporated go public?
- Insmed Incorporated initial public offering (IPO) was on June 1, 2000
- Is Insmed Incorporated in the S&P 500?
- No, Insmed Incorporated is not included in the S&P 500 index
- Is Insmed Incorporated in the NASDAQ 100?
- No, Insmed Incorporated is not included in the NASDAQ 100 index
- Is Insmed Incorporated in the Dow Jones?
- No, Insmed Incorporated is not included in the Dow Jones index
- When was Insmed Incorporated last earnings report?
- Insmed Incorporated's most recent earnings report was on August 6, 2026
- When does Insmed Incorporated report earnings?
- The next expected earnings date for Insmed Incorporated is October 29, 2026
Data Sources & References
- INSM Official Website www.insmed.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1104506/000110450626000009/0001104506-26-000009-index.htm
- INSM Profile on Yahoo Finance finance.yahoo.com/quote/INSM
- INSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/insm
